Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

AGM Statement

20 Jul 2016 07:00

RNS Number : 6661E
Renold PLC
20 July 2016
 

Renold plc

("Renold", "the Company" or "the Group")

 

AGM Statement

 

Renold, a leading international supplier of industrial chains and related power transmission products, is today issuing, ahead of its Annual General Meeting to be held at 11:00am, the following statement in respect of the first quarter of the financial year ending 31 March 2017 ('the Quarter').

 

The Quarter saw overall Group performance in line with expectations. Order intake improvements support the Board's stated expectation of an end to sales declines from the second half of this financial year. As expected, underlying (1) sales in the Quarter were down 9.6% which represents a recovering trend, especially in Chain, from the 11% fall in the second half of the prior year.

 

Underlying Group order intake was 3.1% better than the same period in the prior year with Chain 3.1% ahead and Torque Transmission 3.3% ahead. In Chain, Europe, Australasia and China all delivered growth in underlying order intake. The Americas fell primarily as a result of distributor de-stocking. The trend, however, is an improving one with the fall in the Americas' order intake lower than the previous three quarters. The book to bill ratio for the Group in the Quarter was 110% compared to 96% in the first quarter of the prior year. Underlying orders were £4.0m above underlying sales. In Chain the Book to Bill ratio was 108% (99% in the prior year) and in Torque Transmission 119% (88% in the prior year).

 

It will take time for the full economic and currency implications of the Brexit vote to become clear. However, almost 40% of the Group's external sales are made in the Americas, just under 20% in the continental EU countries and only 8% in the UK. The Group has also not experienced any adverse impact from distributor de-stocking in Europe in the Quarter which had been a feature of the second half of the prior year.

 

The Group continues to implement STEP 2020 strategic initiatives and to invest in new capital equipment. In addition, the integration of the acquired Tooth Chain business continues to proceed smoothly and the business has generated modest growth in order intake and sales compared to the same period prior to the acquisition by Renold.

 

Improving order intake supports an improving outlook for sales in the second half. Continued delivery of STEP 2020 initiatives will add further support to the Group's results. The outlook for the first half and the full year adjusted (2) operating profit therefore remain in line with the Board's expectations.

 

Robert Purcell, Chief Executive of Renold, said:

"Uncertainty and volatility in external markets have been met with the continued delivery of our STEP 2020 Strategic Plan. The Chain division is seeing welcome early signs of lower volatility. The strong growth in Torque Transmission order intake in the period points to an improved outlook for the second half.

 

We continue to invest in growth related activities focussed on expanding our sales foot print and new product development. Multiple initiatives are also underway, focussed on efficiency gains and our cost base to improve further our operational gearing. STEP 2020 remains a robust platform to deliver our goal of mid-teens operating margins."

 

20 July 2016

 

 

 

(1) The use of "underlying" excludes the impact of changes in foreign exchange rates by retranslating the prior year comparative figures to the current year exchange rate.

 (2) Adjusted items exclude exceptional items, the costs of administering closed defined benefit pension schemes, the amortization of acquired intangibles and any associated tax thereon.

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

 

Brian Tenner, Finance Director

 

 

 

Arden Partners

020 7614 5917

Chris Hardie

 

 

 

 

 

Instinctif Partners

020 7457 2020

Mark Garraway

 

Helen Tarbet

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFAFUUFMSESW
Date   Source Headline
18th Jun 202010:37 amRNSDirector/PDMR Shareholding
18th Jun 20208:00 amRNSBlock listing Interim Review
17th Jun 202011:12 amRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSFinal Results
28th May 20203:41 pmRNSHolding(s) in Company
27th May 20207:00 amRNSPreference Stock Dividend
12th May 20207:00 amRNSDirectorate Change
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20202:21 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTrading Update and Impact of Coronavirus
18th Dec 20197:00 amRNSBlock listing Interim Review
27th Nov 20197:00 amRNSPreference Stock Dividend
22nd Nov 20193:00 pmRNSGrant of Award - Performance Share Plan
18th Nov 20199:27 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSDirectorate Changes
13th Nov 20197:00 amRNSHalf-year Report
30th Oct 201912:07 pmRNSSecond Price Monitoring Extn
30th Oct 201912:02 pmRNSPrice Monitoring Extension
14th Oct 20197:00 amRNSTrading Update
20th Sep 20194:58 pmRNSResult of AGM (replacement)
20th Sep 20192:07 pmRNSResult of AGM
27th Aug 20194:05 pmRNSRevised 2019 Annual Report and Accounts
27th Aug 20197:00 amRNSCompletion of investigation
21st Aug 201912:04 pmRNSHolding(s) in Company
17th Jul 20191:23 pmRNSAdjournment of Annual General Meeting 2019
12th Jul 20199:30 amRNSHolding(s) in Company
10th Jul 20199:10 amRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSPostponement of Annual General Meeting
19th Jun 20197:00 amRNSBlock Listing Application
18th Jun 20198:00 amRNSAnnual Report and Accounts
17th Jun 201912:07 pmRNSSecond Price Monitoring Extn
17th Jun 201912:02 pmRNSPrice Monitoring Extension
7th Jun 20198:05 amRNSAdmission to trading on AIM
4th Jun 20195:30 pmRNSRenold
3rd Jun 201911:30 amRNSSchedule One update - Renold plc
3rd Jun 20197:00 amRNSTimetable update
28th May 20197:00 amRNSFinal Results
8th May 20191:54 pmRNSResult of General Meeting
8th May 201911:30 amRNSSchedule 1 - Renold Plc
11th Apr 20192:42 pmRNSPosting of shareholder circular
11th Apr 20197:01 amRNSTrading Update
11th Apr 20197:00 amRNSProposed move from Official List to AIM
1st Apr 20197:00 amRNSExtension of Banking Facilities
4th Feb 20198:00 amRNSBlock listing Interim Review
28th Jan 201912:53 pmRNSHolding(s) in Company
16th Nov 20182:39 pmRNSHolding(s) in Company
16th Nov 20182:38 pmRNSHolding(s) in Company
16th Nov 20182:35 pmRNSHolding(s) in Company
15th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 20187:01 amRNSAppointment of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.